NumerixS Investment Technologies’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-18,600
Closed -$181K 1092
2019
Q4
$181K Buy
+18,600
New +$170K 0.04% 517
2019
Q3
Sell
-900
Closed -$11K 1081
2019
Q2
$11K Buy
+900
New +$11.4K ﹤0.01% 967
2018
Q1
Sell
-3,700
Closed -$53K 1124
2017
Q4
$53K Sell
3,700
-28,300
-88% -$389K 0.01% 841
2017
Q3
$483K Sell
32,000
-27,562
-46% -$365K 0.11% 233
2017
Q2
$600K Sell
59,562
-21,734
-27% -$175K 0.09% 286
2017
Q1
$580K Buy
81,296
+66,196
+438% +$419K 0.07% 361
2016
Q4
$75K Sell
15,100
-65,486
-81% -$453K 0.01% 907
2016
Q3
$596K Buy
80,586
+2,300
+3% +$15.5K 0.08% 327
2016
Q2
$427K Sell
78,286
-5,704
-7% -$39.9K 0.06% 453
2016
Q1
$710K Buy
83,990
+25,231
+43% +$179K 0.08% 344
2015
Q4
$570K Buy
58,759
+47,259
+411% +$426K 0.07% 378
2015
Q3
$161K Buy
+11,500
New +$180K 0.02% 608

Other funds holding FOLD

NumerixS Investment Technologies's FOLD Position: Q1 2020 in Review

NumerixS Investment Technologies sold out of Amicus Therapeutics (FOLD) in Q1 2020, closing a stake of 18,600 shares — an estimated $181K sold.

NumerixS Investment Technologies first reported a position in FOLD in Q3 2015 and held it in 12 quarters. The position peaked at $710K in Q1 2016. 202 funds tracked by Wall St. Rank hold FOLD as of Q1 2020.

  • NumerixS Investment Technologies reported no remaining Amicus Therapeutics position as of Q1 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 18,600 Amicus Therapeutics shares in Q1 2020, an estimated $181K.
  • NumerixS Investment Technologies first reported a position in Amicus Therapeutics in Q3 2015 and held it in 12 quarters.
  • NumerixS Investment Technologies's Amicus Therapeutics position peaked at $710K in Q1 2016.
  • 202 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2020.

Based on NumerixS Investment Technologies's 13F filing for Q1 2020, filed 15 May 2020.